EA201391335A1 - Замещенные дифенильные производные - Google Patents

Замещенные дифенильные производные

Info

Publication number
EA201391335A1
EA201391335A1 EA201391335A EA201391335A EA201391335A1 EA 201391335 A1 EA201391335 A1 EA 201391335A1 EA 201391335 A EA201391335 A EA 201391335A EA 201391335 A EA201391335 A EA 201391335A EA 201391335 A1 EA201391335 A1 EA 201391335A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted diphenyl
diphenyl derivatives
derivatives
substituted
triazene
Prior art date
Application number
EA201391335A
Other languages
English (en)
Other versions
EA024381B1 (ru
Inventor
Хайнц Ферстер
Original Assignee
Криэйтив Терапьютикс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Криэйтив Терапьютикс Гмбх filed Critical Криэйтив Терапьютикс Гмбх
Publication of EA201391335A1 publication Critical patent/EA201391335A1/ru
Publication of EA024381B1 publication Critical patent/EA024381B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • C07C305/22Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/382,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Триазензамещенные дифенильные производные являются подходящими в качестве химиотерапевтических средств для лечения карцином у человека и животных.
EA201391335A 2011-03-16 2012-03-12 Замещенные дифенильные производные EA024381B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011014087 2011-03-16
PCT/DE2012/000258 WO2012122969A1 (de) 2011-03-16 2012-03-12 Substituierte diphenylderivate

Publications (2)

Publication Number Publication Date
EA201391335A1 true EA201391335A1 (ru) 2014-01-30
EA024381B1 EA024381B1 (ru) 2016-09-30

Family

ID=46201039

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391335A EA024381B1 (ru) 2011-03-16 2012-03-12 Замещенные дифенильные производные

Country Status (15)

Country Link
US (1) US9409859B2 (ru)
EP (1) EP2686298B1 (ru)
JP (1) JP2014515734A (ru)
KR (1) KR20140011383A (ru)
CN (1) CN103492365A (ru)
AU (1) AU2012228755B2 (ru)
BR (1) BR112013023316B1 (ru)
CA (1) CA2829998C (ru)
EA (1) EA024381B1 (ru)
ES (1) ES2683306T3 (ru)
IL (1) IL228431A (ru)
MX (1) MX346097B (ru)
SG (1) SG193443A1 (ru)
WO (1) WO2012122969A1 (ru)
ZA (1) ZA201306794B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015008631A1 (de) 2014-10-30 2016-05-04 Creative Therapeutics Gmbh Arzneimittel für die Krebstherapie
CN109293661A (zh) * 2018-10-22 2019-02-01 武汉华星光电半导体显示技术有限公司 近红外光热激活延迟荧光材料及其制备方法、显示装置
DE102020125641A1 (de) 2020-09-25 2022-03-31 Creative Therapeutics Gmbh Wirkstoffe und Arzneimittel für die Therapie von Viruserkrankungen, insbesondere Corona-Infektionen, insbesondere COVID-19

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648660A (en) * 1953-08-11 Process fob
GB691410A (en) * 1950-03-25 1953-05-13 Cfmc Process for the preparation of diazoamino compounds and water-insoluble azodyestuffs on fibres
DE1793115A1 (de) 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
BE789138A (fr) 1971-09-24 1973-03-22 Bayer Ag Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
DE4334823C2 (de) 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
DE10052333A1 (de) 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
DE10324496A1 (de) * 2003-05-30 2004-12-16 Bayer Healthcare Ag Targetorientierte Chemotherapie von Tumoren der Sexualorgane
UA86066C2 (ru) 2004-07-28 2009-03-25 Янссен Фармацевтика Н.В. Производные замещенного пропенилпиперазина как ингибиторы гистондеацетилазы
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
EP2035405A1 (de) 2006-07-05 2009-03-18 Merck Patent GmbH Sulfamat-benzothiophen-derivate
EA201000141A1 (ru) * 2007-07-04 2010-06-30 Трин Фарма Гмбх Новые триазены для лечения рака

Also Published As

Publication number Publication date
EA024381B1 (ru) 2016-09-30
IL228431A (en) 2016-10-31
BR112013023316B1 (pt) 2021-12-14
CA2829998C (en) 2019-07-23
IL228431A0 (en) 2013-12-31
EP2686298A1 (de) 2014-01-22
CA2829998A1 (en) 2012-09-20
MX2013010401A (es) 2014-02-28
AU2012228755B2 (en) 2017-03-23
US9409859B2 (en) 2016-08-09
AU2012228755A1 (en) 2013-09-12
ES2683306T3 (es) 2018-09-26
US20140005149A1 (en) 2014-01-02
ZA201306794B (en) 2014-07-30
JP2014515734A (ja) 2014-07-03
SG193443A1 (en) 2013-10-30
KR20140011383A (ko) 2014-01-28
BR112013023316A2 (pt) 2016-12-06
CN103492365A (zh) 2014-01-01
MX346097B (es) 2017-03-07
WO2012122969A1 (de) 2012-09-20
EP2686298B1 (de) 2018-05-09

Similar Documents

Publication Publication Date Title
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
EA201400178A1 (ru) Лечение рака молочной железы
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
UY34885A (es) Proteínas de unión anti-mesotelina
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34648A (es) Amidas como inhibidores de pim
UY34037A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
UY34559A (es) Inhibidores de bromodominios
UY34039A (es) Compuestos fungicidas
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34503A (es) ?sal de bromhidrato de pridopidina?
UY34051A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
UY33925A (es) Inhibidores tricíclicos de quinasas
UY34165A (es) ?compuestos aldh-2 mitocondriales humanos para el tratamiento de la adicción?.
UY4149Q (es) Golosina para mascota
CL2012003385A1 (es) Tratamiento para la incontinencia.
UY34817A (es) Tienopirimidinas
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
UY34034A (es) Triazolopiridinas
UY34654A (es) Inhibidores de la beta-secretasa
UY34006A (es) Imidazopiridazinas
BR112013024211A2 (pt) tratamento de tumores sólidos
CR20140367A (es) Inhibidores de iap
EA201591024A1 (ru) Димерные соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM